NCT02649790 2025-03-19Study of the Safety, Tolerability and Efficacy of KPT-8602 in Participants With Relapsed/Refractory Cancer IndicationsKaryopharm Therapeutics IncPhase 1/2 Completed277 enrolled
NCT03465540 2023-04-12Safety, Tolerability, Pharmacokinetics and Efficacy of AMG 397 in Subjects With Selected Relapsed or Refractory Hematological MalignanciesAmgenPhase 1 Terminated24 enrolled 21 charts